Cohort Study for Patients Using Fuzeon (Enfuvirtide)
Status:
Unknown status
Trial end date:
2006-12-01
Target enrollment:
Participant gender:
Summary
The Radata-Fuzeon cohort is an observational cohort study to gain a better understanding of
Fuzeon (Enfuvirtide) in daily clinical practice. Patients planned to take this drug in a new
antiretroviral combination therapy (ART) are eligible to participate in this observation.
Physicians may register patients online via the internet. They are offered to get an expert
advice suggesting therapeutics for a new ART.
Observation interval is every three month. However physicians are allowed to initiate new
diagnostics, expert advice and therapeutic changes independently from these intervals if
necessary.
Total observation time for each patients is planned for two years.